Try it
Biochemistry · Amino acid metabolism: asparagine depletion therapy
Sample itemA child with acute lymphoblastic leukaemia is treated with L-asparaginase. What explains the selective toxicity of this enzyme to the leukaemic lymphoblasts?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. They have little asparagine synthetase and depend on circulating asparagine
Normal cells make asparagine from aspartate and glutamine using asparagine synthetase. Many lymphoblasts express little of this enzyme and rely on plasma asparagine, so depleting it halts their protein synthesis while normal cells cope.
Option by option
A. They have little asparagine synthetase and depend on circulating asparagine (correct)
Correct. Low asparagine synthetase leaves the blasts dependent on plasma asparagine, which the drug removes.
B. They overproduce asparagine synthetase and exhaust the aspartate pool
Overproduction would make the cells resistant to the drug, the opposite of what happens.
C. They lack glutamine synthetase and depend on circulating glutamine
The enzyme acts on asparagine, not glutamine, so this does not explain its selectivity.
D. They cannot transaminate oxaloacetate and so lack aspartate
Leukaemic cells can transaminate oxaloacetate; their problem is the final amidation step to asparagine.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…